The stock has declined by around 18% in the last few weeeks alone. With data coming up that could launch this one to the moon why the selling now?. Market is up huge. Biotech has been very strong. Stock held the low 8's fairly well until it broke and it has gone straight down ever since.
Any leak of information could be very limited and selective. Not saying that has happened at all, just that
the volume to me indicates that some holders want out, and now. Every time I have seen this type of action before a major data release I have gotten killed. Not selling in any event...Just sayin the action stinks and I haven't heard any valid reason for that...
biotechlabrat... I don't know how high CEMP can go but it's alot then $21 IMHO...And I bought JUNO at the close on Friday too at $35.50....
Hudson....Agree 100% on the action of late. From years of experience in bios a steady sell off of a stock just before material data is about to be released has always been met with disappointment. Can't think of an exception. I'm of the school that news leaks...good or bad. With that said I'm holding and hoping I'm wrong for the first time on that issue!
Year end could be "year end"...the week of Dec 31st... If so it will not be reported probably until the first week at best in 2015. Then of course there is the issue of timing of the release.
If they presently have the data in hand and it is positive, do you release it in a quiet week with most of the traders gone already for the holidays, or do you wait for the first week in Jan of 2015, when everyone returns and drop the postive data bomb on them then? Could be a much better effect.
If it is negative you proobably would want to release it before year end 2014. That would at least give people some time to tax a tax loss for 2014 before the year ends. Additionally, the drop could be more subdued with more traders gone for the holidays...
I am frankly hoping it is released in 2015....
The key to all of these high yielding midstream and upstream MLP's is whether they will continue to pay the dividends,, and for how long? Even at a reduced rate. For those of you new to these issues (VNR...LGCY...MEMP....BBEP...EVEP...and many others), when you see the size of the dividends
being paid into your accounts now it's mind boggling (if you bought then like I did just a month or so ago).
Doesn't take a genius to figure out if the payout rate can be sustained in some of them from 10%-26%
holding them until the price of crude turns isn't a bad gamble. But I agree...that is a big IF if further
on-going drilling is not economically reasible at $56 bbl...
IMHO really a bad move liebel. You need to read up a tad more on AKAO. They're even having enrollment problems, and have been for quite sometime. They'll be competing against TTPH's antibiotic in the gram negative space as well. You're on the winner of the Kentucky Derby and you don't switch horses a length from
the finish line. LOL...GL to you though...
RXII Down -32.5% YTD One #$%$ off large long for over two years in this company under the premise and hopes that they would develop RNAi products to meet the new needs of modern science in the treatment of major diseases. But on no...They developed a surgical scar drug with only moderate benefits at best over doing nothing...and now they're selling out the company's future for a treatment of viral warts for goodness sakes! Don't mind losing six figures in this POS but these guys clearly ran out of options and took the best road outside of BK for now just to keep the doors open. Where they found this "gem" to save them would probably be worthy of a movie in itself...A comedy for sure, but the ending is a trajedy.
There's a Hapten Sciences in TN...Then a Hapten Pharmaceuticals LLC in NY? Whatever...It's all total nonsense. You have a company searching for a viable drug to possibly build a company around that is so bizzare it's insane. An RNAi company that is now developing a drug that is not RNAi related? This company has no idea where it is going or what will work, or how to fund it...Nothing. Just hanging on by a thread and trying to keep some type of paychecks coming in. Worst company I ever invested in. Out and gone with a nice fat loss, and good luck to whomever is still left in this sinking ship....
John....Dang I missed SNTS but I do have MGNX from the low 18's...lol... What a year in the bios!
Got a gamble going on now witha a data event for CNAT before the end of the year. Do you know anything about them...good...bad...or get the heck out??? LOL Wake me up when CEMP hits 30.....Cheers to all
longs and God help the shorts!
I'm long but don't like the action in advance of some major clinical news....If you're of the school that "news leaks" like I am, I'd like to see the stock up today, rather than down....GLTAL's
Hanna... I agree 100% on everything you just posted. I do think that the surgical scar market could be huge if
we truly have a product that can make a scar virtually become unseen, or even close to it. When 90%
of the observing group points to our treated group as clearly having the better observable scar, then
we may well have something very important to market down the road...